Exchanges At Goldman Sachs
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:26:30
- Mais informações
Informações:
Sinopse
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
